Absolute 0 8 0 8 B-clinical_variable
neutrophil 9 19 9 19 I-clinical_variable
count 20 25 20 25 I-clinical_variable
> 26 27 26 27 O
1.5 28 31 28 31 B-lower_bound
x 32 33 32 33 I-lower_bound
10 34 36 34 36 I-lower_bound
^ 36 37 36 37 I-lower_bound
3 37 38 37 38 I-lower_bound
cells 39 44 39 44 I-lower_bound
/ 44 45 44 45 I-lower_bound
mm^3 45 49 45 49 I-lower_bound
, 49 50 49 50 O
+ 51 52 51 52 O
/- 52 54 52 54 O
7 55 56 55 56 O
days 57 61 57 61 O
from 62 66 62 66 O
date 67 71 67 71 O
of 72 74 72 74 O
ICF 75 78 75 78 O
signing 79 86 79 86 O

Aspartate 0 9 87 96 B-clinical_variable
aminotransferase 10 26 97 113 I-clinical_variable
( 27 28 114 115 I-clinical_variable
AST 28 31 115 118 I-clinical_variable
) 31 32 118 119 I-clinical_variable
or 33 35 120 122 I-clinical_variable
alanine 36 43 123 130 I-clinical_variable
aminotransferase 44 60 131 147 I-clinical_variable
( 61 62 148 149 I-clinical_variable
ALT 62 65 149 152 I-clinical_variable
) 65 66 152 153 I-clinical_variable
= 67 68 154 155 O
< 68 69 155 156 O
5 70 71 157 158 B-upper_bound
x 72 73 159 160 I-upper_bound
ULN 74 77 161 164 I-upper_bound
, 77 78 164 165 O
+ 79 80 166 167 O
/- 80 82 167 169 O
7 83 84 170 171 O
days 85 89 172 176 O
from 90 94 177 181 O
date 95 99 182 186 O
of 100 102 187 189 O
ICF 103 106 190 193 O
signing 107 114 194 201 O

Brain 0 5 202 207 B-treatment
magnetic 6 14 208 216 I-treatment
resonance 15 24 217 226 I-treatment
imaging 25 32 227 234 I-treatment
( 33 34 235 236 I-treatment
MRI 34 37 236 239 I-treatment
) 37 38 239 240 I-treatment
documenting 39 50 241 252 O
CR 51 53 253 255 O
must 54 58 256 260 O
be 59 61 261 263 O
obtained 62 70 264 272 O
within 71 77 273 279 O
30 78 80 280 282 B-upper_bound
days 81 85 283 287 I-upper_bound
of 86 88 288 290 O
study 89 94 291 296 O
enrollment 95 105 297 307 O

CD20 0 4 308 312 O
+ 4 5 312 313 O
B 6 7 314 315 O
- 7 8 315 316 O
cell 8 12 316 320 O
primary 13 20 321 328 B-cancer
central 21 28 329 336 I-cancer
nervous 29 36 337 344 I-cancer
system 37 43 345 351 I-cancer
lymphoma 44 52 352 360 I-cancer
( 53 54 361 362 I-cancer
PCNSL 54 59 362 367 I-cancer
) 59 60 367 368 I-cancer
confirmed 61 70 369 378 O
at 71 73 379 381 O
the 74 77 382 385 O
time 78 82 386 390 O
of 83 85 391 393 O
diagnosis 86 95 394 403 O
by 96 98 404 406 O
histology 99 108 407 416 O
, 108 109 416 417 O
cytology 110 118 418 426 O
, 118 119 426 427 O
or 120 122 428 430 O
immunocytochemistry 123 142 431 450 B-treatment
from 143 147 451 455 O
cerebrospinal 148 161 456 469 O
fluid 162 167 470 475 O
( 168 169 476 477 O
CSF 169 172 477 480 O
) 172 173 480 481 O
; 173 174 481 482 O
diagnosis 175 184 483 492 O
must 185 189 493 497 O
be 190 192 498 500 O
documented 193 203 501 511 O
by 204 206 512 514 O
pathology 207 216 515 524 O
report 217 223 525 531 O

Clinical 0 8 532 540 O
evidence 9 17 541 549 O
of 18 20 550 552 O
extra 21 26 553 558 O
- 26 27 558 559 O
central 27 34 559 566 O
nervous 35 42 567 574 O
system 43 49 575 581 O
( 50 51 582 583 O
CNS 51 54 583 586 O
) 54 55 586 587 O
( 56 57 588 589 O
systemic 57 65 589 597 O
) 65 66 597 598 O
non 67 70 599 602 B-cancer
- 70 71 602 603 I-cancer
Hodgkin 71 78 603 610 I-cancer
lymphoma 79 87 611 619 I-cancer

Creatinine 0 10 620 630 O
clearance 11 20 631 640 I-clinical_variable
> 21 22 641 642 O
30 23 25 643 645 B-lower_bound
mL 26 28 646 648 I-lower_bound
/ 28 29 648 649 I-lower_bound
min 29 32 649 652 I-lower_bound
( 33 34 653 654 O
calculated 34 44 654 664 O
according 45 54 665 674 O
to 55 57 675 677 O
institutional 58 71 678 691 O
standards 72 81 692 701 O
or 82 84 702 704 O
using 85 90 705 710 O
Cockcroft?Gault 91 106 711 726 O
formula 107 114 727 734 O
) 114 115 734 735 O
, 115 116 735 736 O
+ 117 118 737 738 O
/- 118 120 738 740 O
7 121 122 741 742 O
days 123 127 743 747 O
from 128 132 748 752 O
date 133 137 753 757 O
of 138 140 758 760 O
ICF 141 144 761 764 O
signing 145 152 765 772 O

Eastern 0 7 773 780 B-clinical_variable
Cooperative 8 19 781 792 I-clinical_variable
Oncology 20 28 793 801 I-clinical_variable
Group 29 34 802 807 I-clinical_variable
( 35 36 808 809 I-clinical_variable
ECOG 36 40 809 813 I-clinical_variable
) 40 41 813 814 I-clinical_variable
0 42 43 815 816 B-lower_bound
, 43 44 816 817 O
1 45 46 818 819 O
, 46 47 819 820 O
or 48 50 821 823 O
2 51 52 824 825 B-upper_bound

Effective 0 9 826 835 O
contraception 10 23 836 849 B-contraception_consent
is 24 26 850 852 O
required 27 35 853 861 O
while 36 41 862 867 O
receiving 42 51 868 877 O
obinutuzumab 52 64 878 890 B-treatment

Fertile 0 7 891 898 O
men 8 11 899 902 B-gender
or 12 14 903 905 I-gender
women 15 20 906 911 I-gender
of 21 23 912 914 O
childbearing 24 36 915 927 O
potential 37 46 928 937 O
unless 47 53 938 944 O

Hemoglobin 0 10 945 955 B-clinical_variable
> 11 12 956 957 O
9 13 14 958 959 B-lower_bound
g 15 16 960 961 I-lower_bound
/ 16 17 961 962 I-lower_bound
dL 17 19 962 964 I-lower_bound
, 19 20 964 965 O
+ 21 22 966 967 O
/- 22 24 967 969 O
7 25 26 970 971 O
days 27 31 972 976 O
from 32 36 977 981 O
date 37 41 982 986 O
of 42 44 987 989 O
ICF 45 48 990 993 O
signing 49 56 994 1001 O

Hepatitis 0 9 1002 1011 B-chronic_disease
B 10 11 1012 1013 I-chronic_disease
( 12 13 1014 1015 O
HBV 13 16 1015 1018 O
): 16 18 1018 1020 O
patients 19 27 1021 1029 O
with 28 32 1030 1034 O
positive 33 41 1035 1043 O
serology 42 50 1044 1052 O
for 51 54 1053 1056 O
hepatitis 55 64 1057 1066 B-chronic_disease
B 65 66 1067 1068 I-chronic_disease
defined 67 74 1069 1076 O
as 75 77 1077 1079 O
positivity 78 88 1080 1090 O
for 89 92 1091 1094 O
hepatitis 93 102 1095 1104 O
B 103 104 1105 1106 O
surface 105 112 1107 1114 O
antigen 113 120 1115 1122 O
( 121 122 1123 1124 O
HBsAg 122 127 1124 1129 O
) 127 128 1129 1130 O
or 129 131 1131 1133 O
hepatitis 132 141 1134 1143 O
B 142 143 1144 1145 O
core 144 148 1146 1150 O
antibody 149 157 1151 1159 O
( 158 159 1160 1161 O
anti 159 163 1161 1165 O
- 163 164 1165 1166 O
HBc 164 167 1166 1169 O
) 167 168 1169 1170 O

History 0 7 1171 1178 O
of 8 10 1179 1181 O
other 11 16 1182 1187 O
malignancy 17 27 1188 1198 B-cancer
that 28 32 1199 1203 O
could 33 38 1204 1209 O
affect 39 45 1210 1216 O
compliance 46 56 1217 1227 O
with 57 61 1228 1232 O
the 62 65 1233 1236 O
protocol 66 74 1237 1245 O
or 75 77 1246 1248 O
interpretation 78 92 1249 1263 O
of 93 95 1264 1266 O
results 96 103 1267 1274 O

History 0 7 1275 1282 O
of 8 10 1283 1285 O
severe 11 17 1286 1292 O
allergic 18 26 1293 1301 O
or 27 29 1302 1304 O
anaphylactic 30 42 1305 1317 O
reactions 43 52 1318 1327 O
to 53 55 1328 1330 O
monoclonal 56 66 1331 1341 B-allergy_name
antibody 67 75 1342 1350 I-allergy_name
therapy 76 83 1351 1358 I-allergy_name

Karnofsky 0 9 1359 1368 B-clinical_variable
performance 10 21 1369 1380 I-clinical_variable
status 22 28 1381 1387 I-clinical_variable
( 29 30 1388 1389 I-clinical_variable
KPS 30 33 1389 1392 I-clinical_variable
) 33 34 1392 1393 I-clinical_variable
> 35 36 1394 1395 O
= 36 37 1395 1396 O
60 38 40 1397 1399 B-lower_bound

Known 0 5 1400 1405 O
active 6 12 1406 1412 O
bacterial 13 22 1413 1422 B-chronic_disease
, 22 23 1422 1423 O
viral 24 29 1424 1429 B-chronic_disease
, 29 30 1429 1430 O
fungal 31 37 1431 1437 B-chronic_disease
, 37 38 1437 1438 O
mycobacterial 39 52 1439 1452 B-chronic_disease
, 52 53 1452 1453 O
or 54 56 1454 1456 O
other 57 62 1457 1462 O
infection 63 72 1463 1472 B-chronic_disease
( 73 74 1473 1474 O
excluding 74 83 1474 1483 O
fungal 84 90 1484 1490 B-chronic_disease
infections 91 101 1491 1501 I-chronic_disease
of 102 104 1502 1504 O
nail 105 109 1505 1509 O
beds 110 114 1510 1514 O
) 114 115 1514 1515 O
or 116 118 1516 1518 O
any 119 122 1519 1522 O
major 123 128 1523 1528 O
episode 129 136 1529 1536 O
of 137 139 1537 1539 O
infection 140 149 1540 1549 O
requiring 150 159 1550 1559 O
treatment 160 169 1560 1569 B-treatment
with 170 174 1570 1574 I-treatment
IV 175 177 1575 1577 I-treatment
antibiotics 178 189 1578 1589 I-treatment
or 190 192 1590 1592 O
hospitalization 193 208 1593 1608 B-treatment
( 209 210 1609 1610 O
related 210 217 1610 1617 O
to 218 220 1618 1620 O
the 221 224 1621 1624 O
completion 225 235 1625 1635 O
of 236 238 1636 1638 O
the 239 242 1639 1642 O
course 243 249 1643 1649 O
of 250 252 1650 1652 O
antibiotics 253 264 1653 1664 O
) 264 265 1664 1665 O
within 266 272 1666 1672 O
4 273 274 1673 1674 B-upper_bound
weeks 275 280 1675 1680 I-upper_bound
prior 281 286 1681 1686 I-upper_bound
to 287 289 1687 1689 O
study 290 295 1690 1695 O
enrollment 296 306 1696 1706 O

Known 0 5 1707 1712 O
hypersensitivity 6 22 1713 1729 O
to 23 25 1730 1732 O
any 26 29 1733 1736 O
of 30 32 1737 1739 O
the 33 36 1740 1743 O
study 37 42 1744 1749 B-allergy_name
drugs 43 48 1750 1755 I-allergy_name

Known 0 5 1756 1761 O
infection 6 15 1762 1771 B-chronic_disease
with 16 20 1772 1776 O
human 21 26 1777 1782 B-chronic_disease
immunodeficiency 27 43 1783 1799 I-chronic_disease
virus 44 49 1800 1805 I-chronic_disease
( 50 51 1806 1807 I-chronic_disease
HIV 51 54 1807 1810 I-chronic_disease
) 54 55 1810 1811 I-chronic_disease

Major 0 5 1812 1817 B-treatment
surgery 6 13 1818 1825 I-treatment
within 14 20 1826 1832 O
4 21 22 1833 1834 B-upper_bound
weeks 23 28 1835 1840 I-upper_bound
prior 29 34 1841 1846 I-upper_bound
to 35 37 1847 1849 O
study 38 43 1850 1855 O
enrollment 44 54 1856 1866 O

Must 0 4 1867 1871 O
be 5 7 1872 1874 O
within 8 14 1875 1881 O
75 15 17 1882 1884 B-upper_bound
days 18 22 1885 1889 I-upper_bound
of 23 25 1890 1892 O
completion 26 36 1893 1903 O
of 37 39 1904 1906 O
first 40 45 1907 1912 B-treatment
- 45 46 1912 1913 I-treatment
line 46 50 1913 1917 I-treatment
treatment 51 60 1918 1927 I-treatment
regimen 61 68 1928 1935 I-treatment
; 68 69 1935 1936 O
must 70 74 1937 1941 O
have 75 79 1942 1946 O
achieved 80 88 1947 1955 O
complete 89 97 1956 1964 O
response 98 106 1965 1973 O
( 107 108 1974 1975 O
CR 108 110 1975 1977 O
/ 110 111 1977 1978 O
unconfirmed 111 122 1978 1989 O
complete 123 131 1990 1998 O
response 132 140 1999 2007 O
[ 141 142 2008 2009 O
CRu 142 145 2009 2012 O
] 145 146 2012 2013 O
) 146 147 2013 2014 O
to 148 150 2015 2017 O
first 151 156 2018 2023 O
- 156 157 2023 2024 O
line 157 161 2024 2028 O
treatment 162 171 2029 2038 O

Must 0 4 2039 2043 O
have 5 9 2044 2048 O
undergone 10 19 2049 2058 O
first 20 25 2059 2064 O
- 25 26 2064 2065 O
line 26 30 2065 2069 O
treatment 31 40 2070 2079 B-treatment
with 41 45 2080 2084 O
a 46 47 2085 2086 O
high 48 52 2087 2091 O
- 52 53 2091 2092 O
dose 53 57 2092 2096 O
methotrexate 58 70 2097 2109 B-treatment
- 70 71 2109 2110 I-treatment
based 71 76 2110 2115 I-treatment
chemotherapy 77 89 2116 2128 I-treatment
regimen 90 97 2129 2136 I-treatment
with 98 102 2137 2141 O
or 103 105 2142 2144 O
without 106 113 2145 2152 O
brain 114 119 2153 2158 B-treatment
radiotherapy 120 132 2159 2171 I-treatment

Patients 0 8 2172 2180 O
with 9 13 2181 2185 O
a 14 15 2186 2187 O
history 16 23 2188 2195 O
of 24 26 2196 2198 O
curatively 27 37 2199 2209 O
treated 38 45 2210 2217 O
basal 46 51 2218 2223 B-cancer
or 52 54 2224 2226 O
squamous 55 63 2227 2235 B-cancer
cell 64 68 2236 2240 I-cancer
carcinoma 69 78 2241 2250 I-cancer
of 79 81 2251 2253 I-cancer
the 82 85 2254 2257 I-cancer
skin 86 90 2258 2262 I-cancer
or 91 93 2263 2265 O
in 94 96 2266 2268 B-cancer
situ 97 101 2269 2273 I-cancer
carcinoma 102 111 2274 2283 I-cancer
of 112 114 2284 2286 I-cancer
the 115 118 2287 2290 I-cancer
cervix 119 125 2291 2297 I-cancer

Platelet 0 8 2298 2306 B-clinical_variable
> 9 10 2307 2308 O
= 10 11 2308 2309 O
75,000 12 18 2310 2316 B-lower_bound
cells 19 24 2317 2322 I-lower_bound
/ 24 25 2322 2323 I-lower_bound
mm^3 25 29 2323 2327 I-lower_bound
, 29 30 2327 2328 O
+ 31 32 2329 2330 O
/- 32 34 2330 2332 O
7 35 36 2333 2334 B-lower_bound
days 37 41 2335 2339 I-lower_bound
from 42 46 2340 2344 O
date 47 51 2345 2349 O
of 52 54 2350 2352 O
ICF 55 58 2353 2356 O
signing 59 66 2357 2364 O

Surgically 0 10 2365 2375 B-treatment
sterile 11 18 2376 2383 I-treatment
or 19 21 2384 2386 O
agree 22 27 2387 2392 B-contraception_consent
to 28 30 2393 2395 I-contraception_consent
use 31 34 2396 2399 I-contraception_consent
effective 35 44 2400 2409 I-contraception_consent
contraception 45 58 2410 2423 I-contraception_consent
using 59 64 2424 2429 I-contraception_consent
an 65 67 2430 2432 I-contraception_consent
adequate 68 76 2433 2441 I-contraception_consent
measure 77 84 2442 2449 I-contraception_consent
of 85 87 2450 2452 I-contraception_consent
contraception 88 101 2453 2466 I-contraception_consent
such 102 106 2467 2471 O
as 107 109 2472 2474 O
oral 110 114 2475 2479 B-contraception_consent
contraceptives 115 129 2480 2494 I-contraception_consent
, 129 130 2494 2495 O
intrauterine 131 143 2496 2508 B-contraception_consent
device 144 150 2509 2515 I-contraception_consent
, 150 151 2515 2516 O
or 152 154 2517 2519 O
barrier 155 162 2520 2527 B-contraception_consent
method 163 169 2528 2534 I-contraception_consent
of 170 172 2535 2537 I-contraception_consent
contraception 173 186 2538 2551 I-contraception_consent
in 187 189 2552 2554 O
conjunction 190 201 2555 2566 O
with 202 206 2567 2571 O
spermicidal 207 218 2572 2583 B-contraception_consent
jelly 219 224 2584 2589 I-contraception_consent
while 225 230 2590 2595 O
receiving 231 240 2596 2605 O
obinutuzumab 241 253 2606 2618 B-treatment
and 254 257 2619 2622 O
> 258 259 2623 2624 O
= 259 260 2624 2625 O
12 261 263 2626 2628 B-lower_bound
months 264 270 2629 2635 I-lower_bound
after 271 276 2636 2641 I-lower_bound
the 277 280 2642 2645 O
last 281 285 2646 2650 O
dose 286 290 2651 2655 O
of 291 293 2656 2658 O
obinutuzumab 294 306 2659 2671 O
for 307 310 2672 2675 O
women 311 316 2676 2681 B-gender
, 316 317 2681 2682 O
and 318 321 2683 2686 O
3 322 323 2687 2688 B-lower_bound
months 324 330 2689 2695 I-lower_bound
after 331 336 2696 2701 I-lower_bound
the 337 340 2702 2705 O
last 341 345 2706 2710 O
dose 346 350 2711 2715 O
of 351 353 2716 2718 O
obinutuzumab 354 366 2719 2731 O
for 367 370 2732 2735 O
men 371 374 2736 2739 O

Total 0 5 2740 2745 B-clinical_variable
bilirubin 6 15 2746 2755 I-clinical_variable
< 16 17 2756 2757 O
3 18 19 2758 2759 B-upper_bound
x 20 21 2760 2761 I-upper_bound
the 22 25 2762 2765 I-upper_bound
upper 26 31 2766 2771 I-upper_bound
limit 32 37 2772 2777 I-upper_bound
of 38 40 2778 2780 I-upper_bound
normal 41 47 2781 2787 I-upper_bound
( 48 49 2788 2789 I-upper_bound
ULN 49 52 2789 2792 I-upper_bound
) 52 53 2792 2793 I-upper_bound
, 53 54 2793 2794 O
+ 55 56 2795 2796 O
/- 56 58 2796 2798 O
7 59 60 2799 2800 O
days 61 65 2801 2805 O
from 66 70 2806 2810 O
date 71 75 2811 2815 O
of 76 78 2816 2818 O
ICF 79 82 2819 2822 O
signing 83 90 2823 2830 O

Vaccination 0 11 2831 2842 B-treatment
with 12 16 2843 2847 I-treatment
a 17 18 2848 2849 I-treatment
live 19 23 2850 2854 I-treatment
vaccine 24 31 2855 2862 I-treatment
a 32 33 2863 2864 O
minimum 34 41 2865 2872 O
of 42 44 2873 2875 O
4 45 46 2876 2877 B-lower_bound
weeks 47 52 2878 2883 I-lower_bound
prior 53 58 2884 2889 I-lower_bound
to 59 61 2890 2892 O
study 62 67 2893 2898 O
enrollment 68 78 2899 2909 O

Women 0 5 2910 2915 B-gender
who 6 9 2916 2919 O
are 10 13 2920 2923 O
pregnant 14 22 2924 2932 B-pregnancy

for 0 3 2933 2936 O
men 4 7 2937 2940 B-gender
, 7 8 2940 2941 O
effective 9 18 2942 2951 B-contraception_consent
contraception 19 32 2952 2965 I-contraception_consent
is 33 35 2966 2968 O
required 36 44 2969 2977 O
to 45 47 2978 2980 O
continue 48 56 2981 2989 O
for 57 60 2990 2993 O
3 61 62 2994 2995 B-upper_bound
months 63 69 2996 3002 I-upper_bound
after 70 75 3003 3008 I-upper_bound
the 76 79 3009 3012 O
last 80 84 3013 3017 O
dose 85 89 3018 3022 O
of 90 92 3023 3025 O
obinutuzumab 93 105 3026 3038 B-treatment
treatment 106 115 3039 3048 B-treatment

for 0 3 3049 3052 O
women 4 9 3053 3058 B-gender
, 9 10 3058 3059 O
effective 11 20 3060 3069 B-contraception_consent
contraception 21 34 3070 3083 I-contraception_consent
is 35 37 3084 3086 O
required 38 46 3087 3095 O
to 47 49 3096 3098 O
continue 50 58 3099 3107 O
for 59 62 3108 3111 O
> 63 64 3112 3113 O
= 64 65 3113 3114 O
12 66 68 3115 3117 B-lower_bound
months 69 75 3118 3124 I-lower_bound
after 76 81 3125 3130 I-lower_bound
the 82 85 3131 3134 O
last 86 90 3135 3139 O
dose 91 95 3140 3144 O
of 96 98 3145 3147 O
obinutuzumab 99 111 3148 3160 B-treatment

high 0 4 3161 3165 O
- 4 5 3165 3166 O
dose 5 9 3166 3170 O
methotrexate 10 22 3171 3183 B-treatment
is 23 25 3184 3186 O
defined 26 33 3187 3194 O
as 34 36 3195 3197 O
> 37 38 3198 3199 O
= 38 39 3199 3200 O
3 40 41 3201 3202 B-lower_bound
grams 42 47 3203 3208 I-lower_bound
/ 47 48 3208 3209 I-lower_bound
m^2 48 51 3209 3212 I-lower_bound
; 51 52 3212 3213 O
methotrexate 53 65 3214 3226 O
dose 66 70 3227 3231 O
reduction 71 80 3232 3241 O
for 81 84 3242 3245 O
creatinine 85 95 3246 3256 B-clinical_variable
clearance 96 105 3257 3266 I-clinical_variable
< 106 107 3267 3268 O
100 108 111 3269 3272 B-upper_bound
ml 112 114 3273 3275 I-upper_bound
/ 114 115 3275 3276 I-upper_bound
min 115 118 3276 3279 I-upper_bound
is 119 121 3280 3282 O
permitted 122 131 3283 3292 O

patients 0 8 3293 3301 O
with 9 13 3302 3306 O
positive 14 22 3307 3315 O
serology 23 31 3316 3324 B-treatment
may 32 35 3325 3328 O
be 36 38 3329 3331 O
referred 39 47 3332 3340 O
to 48 50 3341 3343 O
a 51 52 3344 3345 O
hepatologist 53 65 3346 3358 O
or 66 68 3359 3361 O
gastroenterologist 69 87 3362 3380 O
for 88 91 3381 3384 O
appropriate 92 103 3385 3396 O
monitoring 104 114 3397 3407 O
and 115 118 3408 3411 O
management 119 129 3412 3422 O

surgically 0 10 3423 3433 B-treatment
sterile 11 18 3434 3441 I-treatment

using 0 5 3442 3447 B-contraception_consent
an 6 8 3448 3450 I-contraception_consent
adequate 9 17 3451 3459 I-contraception_consent
measure 18 25 3460 3467 I-contraception_consent
of 26 28 3468 3470 I-contraception_consent
contraception 29 42 3471 3484 I-contraception_consent
such 43 47 3485 3489 O
as 48 50 3490 3492 O
oral 51 55 3493 3497 B-contraception_consent
contraceptives 56 70 3498 3512 I-contraception_consent
, 70 71 3512 3513 O
intrauterine 72 84 3514 3526 B-contraception_consent
device 85 91 3527 3533 I-contraception_consent
, 91 92 3533 3534 O
or 93 95 3535 3537 O
barrier 96 103 3538 3545 B-contraception_consent
method 104 110 3546 3552 I-contraception_consent
of 111 113 3553 3555 I-contraception_consent
contraception 114 127 3556 3569 I-contraception_consent
in 128 130 3570 3572 I-contraception_consent
conjunction 131 142 3573 3584 I-contraception_consent
with 143 147 3585 3589 I-contraception_consent
spermicidal 148 159 3590 3601 I-contraception_consent
jelly 160 165 3602 3607 I-contraception_consent

